Roundtable: Increasing the Robustness of IVPT Experiments

In a recent Analytical Special Feature with Drug Development & Delivery, industry experts weigh in about the the impacts of AI and automation in analytical labs.

MedPharm CSO, Dr. Jon Lenn, discusses our unique automated diffusion cell system, MedFlux-HT®, and transepidermal water loss (TEWL) instrument used for IVPT studies.

Learn more about the advantages of these systems in the lab, and read the full feature here.

MedPharm CSO, Dr. Jon Lenn